Glenmark Pharmaceuticals Inc., USA recalls Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceutica
Recalled December 26, 2018 · FDA recall D-0349-2019 · Glenmark Pharmaceuticals Inc., USA
Hazard
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack. · FDA Class III
Units
5,016 blister packs
Sold at
Nationwide
Description
Shortfill: Aprepitant capsules 40 mg is being recalled due to customer reports of missing capsule in the blister pack.
Product
Aprepitant Capsules, USP 40 mg, 1 capsule Unit Blister Pack, Rx Only, Manufactured in India for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. UPC 368462583401. NDC 68462-583-40
Manufacturer(s)
Glenmark Pharmaceuticals Inc., USA
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →